Cargando…

Black lung persistent pulmonary hypertension of the newborn: Saudi experience with sildenafil and nitric oxide

OBJECTIVES: To determine the clinical presentation, risk factors, diagnosis, and treatment outcome of Saudi infants with black lung persistent pulmonary hypertension of the newborn (PPHN). METHODS: This is a retrospective review of all neonates with PPHN presented to the Armed Force Hospital Souther...

Descripción completa

Detalles Bibliográficos
Autor principal:	Alnemri, AbdulRahman M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Saudi Medical Journal 2017
Materias:	Brief Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5278074/ https://www.ncbi.nlm.nih.gov/pubmed/28042638 http://dx.doi.org/10.15537/smj.2017.1.16223

Ejemplares similares

Efficacy, safety and tolerability of bosentan as an adjuvant to sildenafil and sildenafil alone in persistant pulmonary hypertension of newborn (PPHN)
por: Vijay Kumar, J.R., et al.
Publicado: (2021)

Clinical response to inhaled nitric oxide in persistent pulmonary hypertension of the newborn.
por: Ko, S. Y., et al.
Publicado: (1998)

Sildenafil Improves Pulmonary Vascular Remodeling in a Rat Model of Persistent Pulmonary Hypertension of the Newborn
por: Kang, Lili, et al.
Publicado: (2022)

Bosentan and sildenafil in the treatment of HIV-associated pulmonary hypertension
por: Chinello, Pierangelo, et al.
Publicado: (2011)

Inhaled nitric oxide in persistent pulmonary hypertension of the newborn refractory to high-frequency ventilation
por: Al-Alaiyan, Saleh, et al.
Publicado: (1999)

Is Sildenafil an Effective Therapy in the Management of Persistent Pulmonary Hypertension?
por: Yaseen, Hakam, et al.
Publicado: (2012)

Comparison of treprostinil and oral sildenafil for the treatment of persistent pulmonary hypertension of the newborn: a retrospective cohort study
por: Wei, Enhuan, et al.
Publicado: (2023)

Efficacy of Sildenafil in Infants with Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension
por: Dillon, Kacie, et al.
Publicado: (2023)

Comparison of intravenous sildenafil with inhaled nitric oxide for acute vasodilator testing in pulmonary arterial hypertension
por: Kumar, Shine, et al.
Publicado: (2022)

Persistent Pulmonary Hypertension of the Newborn: The Efficacy Comparison of Vasodilators Sildenafil Plus Bosentan Versus Sildenafil Plus Beraprost at a Tertiary Childcare Health Facility
por: Adnan, Mudasser, et al.
Publicado: (2021)

Use of off-label compounded oral sildenafil in the management of persistent pulmonary hypertension of the newborn: A case report
por: Daniyan, Olapeju, et al.
Publicado: (2022)

Inhaled nitric oxide for neonates with persistent pulmonary hypertension of the newborn in the CINRGI study: time to treatment response
por: Nelin, Leif D., et al.
Publicado: (2019)

Clinical Efficacy and Safety of Different Doses of Sildenafil in the Treatment of Persistent Pulmonary Hypertension of the Newborn: A Network Meta-analysis
por: Sun, Linli, et al.
Publicado: (2021)

Nitric oxide therapy in persistent pulmonary hypertension of the newborns (PPHN): predictors of survival in a single center experience
por: Maruniak-Chudek, I, et al.
Publicado: (2003)

Comparison between the Acute Pulmonary Vascular Effects of Oxygen with Nitric Oxide and Sildenafil
por: Day, Ronald W.
Publicado: (2015)

Sildenafil in the treatment of pulmonary hypertension
por: Barnett, Christopher F, et al.
Publicado: (2006)

Persistent pulmonary hypertension of the newborn
por: Sharma, Vinay, et al.
Publicado: (2015)

Persistent Pulmonary Hypertension in the Newborn
por: Mathew, Bobby, et al.
Publicado: (2017)

Severe neonatal pulmonary hypertension secondary to antenatal maternal diclofenac ingestion reversed by inhaled nitric oxide and oral sildenafil
por: Mersal, Ali, et al.
Publicado: (2007)

Use of sildenafil in an infant with persistent pulmonary hypertension secondary to lung and renal hypoplasia – a case report
por: Lavie-Nevo, Karen, et al.
Publicado: (2019)

Sildenafil in pediatric pulmonary arterial hypertension
por: Dhariwal, AK, et al.
Publicado: (2015)

Correlation of ABO blood groups with treatment response and efficacy in infants with persistent pulmonary hypertension of the newborn treated with inhaled nitric oxide
por: Guan, Yi, et al.
Publicado: (2023)

Nitric oxide and pulmonary hypertension
por: Sim, Ji-Yeon
Publicado: (2010)

Pharmacokinetic and Pharmacodynamic Comparison of Sildenafil‐Bosentan and Sildenafil‐Ambrisentan Combination Therapies for Pulmonary Hypertension
por: Hakamata, A, et al.
Publicado: (2016)

Inhaled nitric oxide decreases pulmonary endothelial nitric oxide synthase expression and activity in normal newborn rat lungs
por: Hua-Huy, Thông, et al.
Publicado: (2016)

Patient Characteristics in Persistent Pulmonary Hypertension of the Newborn
por: Roofthooft, M. T. R., et al.
Publicado: (2011)

Risk factors for persistent pulmonary hypertension of the newborn
por: Delaney, Cassidy, et al.
Publicado: (2012)

Altered metabolites in newborns with persistent pulmonary hypertension
por: Steurer, Martina A., et al.
Publicado: (2018)

Effect of sildenafil-induced nitric oxide on the histomorphology of cardiomyocytes in male rats
por: Prabhu, Latha V, et al.
Publicado: (2013)

Improving coordination of lung cancer care at a tertiary healthcare center in Saudi Arabia
por: Alkhathlan, Abeer, et al.
Publicado: (2022)

Nitric oxide and pulmonary arterial hypertension
por: Chester, Adrian H., et al.
Publicado: (2017)

Sildenafil in endotoxin-induced pulmonary hypertension: an experimental study
por: Kemper, Daniella Aparecida Godoi, et al.
Publicado: (2021)

A randomized, double-blind, placebo-controlled study to evaluate sildenafil, ambrisentan combination therapy in pulmonary hypertension, particularly of Eisenmenger syndrome
por: Mohammed, Shaadab, et al.
Publicado: (2021)

Postnatal causes and severity of persistent pulmonary Hypertension of Newborn
por: Arshad, Muhammad Sohail, et al.
Publicado: (2021)

Diastolic ventricular function in persistent pulmonary hypertension of the newborn
por: Le Duc, Kévin, et al.
Publicado: (2023)

Pulmonary arterial size and response to sildenafil in chronic thromboembolic pulmonary hypertension
por: Toshner, Mark R., et al.
Publicado: (2010)

Atorvastatin and sildenafil lower blood pressure and improve endothelial dysfunction, but only atorvastatin increases vascular stores of nitric oxide in hypertension()
por: Guimarães, Danielle A., et al.
Publicado: (2013)

Comparison of preventive effect of sildenafil and therapeutic effect of sildenafil treatment in rats with monocrotaline-induced pulmonary arterial hypertension
por: YOSHIYUKI, Rieko, et al.
Publicado: (2016)

Clinical deterioration after sildenafil cessation in patients with pulmonary hypertension
por: Keogh, Anne M, et al.
Publicado: (2008)

Simvastatin, Sildenafil and Their Combination in Monocrotaline Induced Pulmonary Arterial Hypertension
por: Lee, Dong Seok, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_pe7f8rbbrthaor96bh6ggk0fqq